• aVaxziPen Revolutionizes Vaccine Delivery for Enhanced Accessibility and Distribution

  6th June 2023

  Originally published in BioStartUps aVaxziPen Ltd, a biotech company developing a novel needle-free vaccine delivery platform, have today announced a partnership to advance the development of two vaccines candidates (one protein and one mRNA-based) using aVaxziPen’s solid dose vaccine-delivery platform, which could help end the need for frozen storage of vaccines, thereby improving equitable access… read more

• The world has long needed a better vaccine delivery system.” The time of the hollow needle is over – solid dose vaccines are the future

  24th May 2023

  Originally published by the Medicine Maker I could easily argue that vaccines are the biggest success story of modern medicine; millions of lives are saved across the globe every year through vaccination programs that protect entire populations from a diverse and evolving range of pathogens. Vaccines were already contributing much before COVID-19, but the pandemic demanded… read more

• aVaxziPen’s needle-free vaccine yields positive data across multiple diseases

  18th May 2023

  Originally published in LABIOTECH aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, presented data at the World Vaccine Congress (WVC) in Washington, U.S., recently.  The company presented a poster entitled, “Needle-free, injectable solid dose vaccine delivery generates equivalent immune response with different antigens and animal models.” The company said immunogenicity data from… read more